Saturday, July 11, 2026

Drug profile · INN

teneligliptin

teneligliptin is a dipeptidyl peptidase iv inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — teneligliptin
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

teneligliptin is a dipeptidyl peptidase iv inhibitor.

Key facts

INN teneligliptin
Mechanism Dipeptidyl peptidase IV inhibitor
Target Dipeptidyl peptidase 4

Mechanism of action

Dipeptidyl peptidase IV inhibitor

Primary target: Dipeptidyl peptidase 4

Approval history

Authority Status Date
NMPA clinical trials

Related & competitor drugs

  1. alogliptin benzoate Alimentary tract and metabolism (A10)
  2. linagliptin Alimentary tract and metabolism (A10)
  3. saxagliptin hydrochloride Dipeptidyl peptidase IV inhibitor
  4. sitagliptin phosphate Dipeptidyl peptidase IV inhibitor
  5. begelomab Antineoplastic and immunomodulating agents (L04)
  6. sitagliptin fumarate Alimentary tract and metabolism (A10)

Frequently asked questions

What is teneligliptin?

teneligliptin is a dipeptidyl peptidase iv inhibitor.